Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience

Table 1

Characteristics of patients (𝑛=85).

Mean age	50 years	21–70
Mean CA 125 before; SLL	1879 UI/mL	21–31599
FIGO stage	II	13 (15%)
	III	63 (74%)
	IV	9 (11%)
Histological types	Serous	57 (67.1%)
	Endometrial	11 (12.9%)
	Mucinous	4 (4.7%)
	Mixed	4 (4.7%)
	Unclassified types	9 (10.6%)
Grade	I	3 (3.5%)
	II	12 (14.1%)
	III	14 (16.5%)
Optimal cytoreduction after primary surgery (R<1 cm)	FIGO II–IV	55 (64.7%)
Type of primary chemotherapy	Cisplatin-cyclophosphamide	68  (70%)
	Carboplatin-paclitaxel	17  (30%)
SLL duration	120.1 min	45–240 min
Hospital stay after SLL	8.5 days	5–26